<!DOCTYPE html>
<html>
  <head>
      
    <base href="https://maurofaccin.github.io">
    <title>Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">

    <link href="../../css/style.css" rel="stylesheet" media="screen">
    <link rel="shortcut icon" href="../../images/favicon.ico" type="image/x-icon">


  </head>

  <body>
      
      
<nav>
    <ul>
        <a class='home' href="../../"><li><strong>Mauro Faccin</strong></li></a>
        <input type="checkbox" name="MENU" id="MENU"/>
        <label for="MENU">MENU</label>

        

        
        <a href="../../papers/">
            <li>Publications</li></a>
        
        <a href="../../slides/">
            <li>Slides &amp; Posters</li></a>
        
        <a href="../../codes/">
            <li>Codes</li></a>
        
        <a href="../../cv/">
            <li>Curriculum Vitæ</li></a>
        
        <a href="../../contacts/">
            <li>Contacts</li></a>
        
    </ul>
</nav>

      

      
      
    <div class="jumbotron">
	    <h1>Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study</h1>
	    
	    <i><h4>


    
    
        
    

    
    
        
    

    
    
        
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    

    
    
        
    



<i> Makhado, Matabane, <a class="underline" href="https://maurofaccin.github.io/" target="_blank">Faccin</a>, Pinçon, Jouet, Boutachkourt, Goeminne, Gaudin, Maphalala, Beckert, Niemann, <a class="underline" href="https://perso.uclouvain.be/jean-charles.delvenne/welcome.html" target="_blank">Delvenne</a>, Delmée, Razwiedani, Nchabeleng, Supply, de Jong and André </i><br>


</h4></i>
	    <h4> 
<b><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2818%2930496-1/fulltext" target="_blank">The Lancet Infectious Diseases, 2018</a></b><br>

<br> </h4>
	     
    </div>

      

      
<section>
    <main>

        
        
    
    
    <input class="popup" type="checkbox" id="Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study">
    <label class="popup" for="Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study">
        <div class="button col2">BibTeX</div>
        <div class="hidden"><pre>@article{makhado2018outbreak_drugresistant,
    title = {Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study},
    journal = {The Lancet Infectious Diseases},
    year = {2018},
    issn = {1473-3099},
    doi = {https://doi.org/10.1016/S1473-3099(18)30496-1},
    url = {http://www.sciencedirect.com/science/article/pii/S1473309918304961},
    author = {Ndivhuho A Makhado and Edith Matabane and Mauro Faccin and Claire Pinçon and Agathe Jouet and Fairouz Boutachkourt and Léonie Goeminne and Cyril Gaudin and Gugu Maphalala and Patrick Beckert and Stefan Niemann and Jean-Charles Delvenne and Michel Delmée and Lufuno Razwiedani and Maphoshane Nchabeleng and Philip Supply and Bouke C de Jong and Emmanuel André}
}</pre></div>
    </label>
    
    


        
        <aside><figure>
                <img width="100%" src="../../papers/2018-10-17-tubercolosis-RSA-SWA-thelancet/map-with-dendrogram.png" alt="Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study" />
            </figure></aside>
            

            <h3>Abstract:</h3>
            Global roll-out of rapid molecular assays is revolutionising the diagnosis of rifampicin resistance, predictive of multidrug-resistance, in tuberculosis.  However, 30% of the multidrug-resistant (MDR) strains in an eSwatini study harboured the Ile491Phe mutation in the rpoB gene, which is associated with poor rifampicin-based treatment outcomes but is missed by commercial molecular assays or scored as susceptible by phenotypic drug-susceptibility testing deployed in South Africa. We evaluated the presence of Ile491Phe among South African tuberculosis isolates reported as isoniazid-monoresistant according to current national testing algorithms.
    </main>
</section>


      
          <footer>
    </footer>



      
  </body>
</html>

